Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.

Maertens JA, Girmenia C, Brüggemann RJ, Duarte RF, Kibbler CC, Ljungman P, Racil Z, Ribaud P, Slavin MA, Cornely OA, Peter Donnelly J, Cordonnier C; European Conference on Infections in Leukaemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and; European Conference on Infections in Leukaemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN) .

J Antimicrob Chemother. 2018 Dec 1;73(12):3221-3230. doi: 10.1093/jac/dky286.

PMID:
30085172
2.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

3.

Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units.

Shahin J, Allen EJ, Patel K, Muskett H, Harvey SE, Edgeworth J, Kibbler CC, Barnes RA, Biswas S, Soni N, Rowan KM, Harrison DA; FIRE Study Investigators.

BMC Infect Dis. 2016 Sep 9;16:480. doi: 10.1186/s12879-016-1803-9.

4.

Early invasive fungal infections and colonization in patients with cirrhosis admitted to the intensive care unit.

Theocharidou E, Agarwal B, Jeffrey G, Jalan R, Harrison D, Burroughs AK, Kibbler CC.

Clin Microbiol Infect. 2016 Feb;22(2):189.e1-189.e7. doi: 10.1016/j.cmi.2015.10.020. Epub 2015 Nov 10.

5.

Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus.

van der Linden JW, Arendrup MC, Warris A, Lagrou K, Pelloux H, Hauser PM, Chryssanthou E, Mellado E, Kidd SE, Tortorano AM, Dannaoui E, Gaustad P, Baddley JW, Uekötter A, Lass-Flörl C, Klimko N, Moore CB, Denning DW, Pasqualotto AC, Kibbler C, Arikan-Akdagli S, Andes D, Meletiadis J, Naumiuk L, Nucci M, Melchers WJ, Verweij PE.

Emerg Infect Dis. 2015 Jun;21(6):1041-4. doi: 10.3201/eid2106.140717.

6.

Improved Standardization of the Bio-Rad Platelia Aspergillus Galactomannan Antigen Sandwich Enzyme Immunoassay Using the DS2 (Dynex) Enzyme-Linked Immunosorbent Assay (ELISA) Processing System.

Gorton RL, White PL, Bagkeris E, Cotterall D, Desai R, McHugh T, Kibbler CC.

J Clin Microbiol. 2015 Jul;53(7):2072-8. doi: 10.1128/JCM.00157-15. Epub 2015 Apr 15.

7.

Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031).

Cornely OA, Gachot B, Akan H, Bassetti M, Uzun O, Kibbler C, Marchetti O, de Burghgraeve P, Ramadan S, Pylkkanen L, Ameye L, Paesmans M, Donnelly JP; EORTC Infectious Diseases Group.

Clin Infect Dis. 2015 Aug 1;61(3):324-31. doi: 10.1093/cid/civ293. Epub 2015 Apr 13. Erratum in: Clin Infect Dis. 2015 Nov 15;61(10):1635. Donnelly, Peter J [corrected to Donnelly, J Peter].

PMID:
25870323
8.

British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases.

Schelenz S, Barnes RA, Barton RC, Cleverley JR, Lucas SB, Kibbler CC, Denning DW; British Society for Medical Mycology.

Lancet Infect Dis. 2015 Apr;15(4):461-74. doi: 10.1016/S1473-3099(15)70006-X. Epub 2015 Mar 12. Review.

PMID:
25771341
9.

Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006-2008).

Klingspor L, Tortorano AM, Peman J, Willinger B, Hamal P, Sendid B, Velegraki A, Kibbler C, Meis JF, Sabino R, Ruhnke M, Arikan-Akdagli S, Salonen J, Dóczi I.

Clin Microbiol Infect. 2015 Jan;21(1):87.e1-87.e10. doi: 10.1016/j.cmi.2014.08.011. Epub 2014 Oct 12.

10.

A comprehensive diagnostic approach using galactomannan, targeted β-d-glucan, baseline computerized tomography and biopsy yields a significant burden of invasive fungal disease in at risk haematology patients.

Ceesay MM, Desai SR, Berry L, Cleverley J, Kibbler CC, Pomplun S, Nicholson AG, Douiri A, Wade J, Smith M, Mufti GJ, Pagliuca A.

Br J Haematol. 2015 Jan;168(2):219-29. doi: 10.1111/bjh.13114. Epub 2014 Sep 1.

PMID:
25179933
11.

Comparative analysis of Gram's stain, PNA-FISH and Sepsityper with MALDI-TOF MS for the identification of yeast direct from positive blood cultures.

Gorton RL, Ramnarain P, Barker K, Stone N, Rattenbury S, McHugh TD, Kibbler CC.

Mycoses. 2014 Oct;57(10):592-601. doi: 10.1111/myc.12205. Epub 2014 May 26.

PMID:
24862948
12.

Evaluation of a short, on-plate formic acid extraction method for matrix-assisted laser desorption ionization-time of flight mass spectrometry-based identification of clinically relevant yeast isolates.

Gorton RL, Seaton S, Ramnarain P, McHugh TD, Kibbler CC.

J Clin Microbiol. 2014 Apr;52(4):1253-5. doi: 10.1128/JCM.03489-13. Epub 2014 Jan 29.

13.

Candida nivariensis isolated from a renal transplant patient with persistent candiduria-Molecular identification using ITS PCR and MALDI-TOF.

Gorton RL, Jones GL, Kibbler CC, Collier S.

Med Mycol Case Rep. 2013 Oct 25;2:156-8. doi: 10.1016/j.mmcr.2013.10.001. eCollection 2013 Oct 25.

14.

Infections in patients taking Rituximab for hematologic malignancies: two-year cohort study.

Lanini S, Molloy AC, Prentice AG, Ippolito G, Kibbler CC.

BMC Infect Dis. 2013 Jul 12;13:317. doi: 10.1186/1471-2334-13-317.

15.

Evaluation of PNA-FISH yeast traffic light for rapid identification of yeast directly from positive blood cultures and assessment of clinical impact.

Stone NR, Gorton RL, Barker K, Ramnarain P, Kibbler CC.

J Clin Microbiol. 2013 Apr;51(4):1301-2. doi: 10.1128/JCM.00028-13. Epub 2013 Feb 6.

16.

Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive Candida infection: the Fungal Infection Risk Evaluation (FIRE) Study.

Harrison D, Muskett H, Harvey S, Grieve R, Shahin J, Patel K, Sadique Z, Allen E, Dybowski R, Jit M, Edgeworth J, Kibbler C, Barnes R, Soni N, Rowan K.

Health Technol Assess. 2013 Feb;17(3):1-156. doi: 10.3310/hta17030. Review.

17.

Outcomes and patterns of infections in patients with underlying haematological malignancies admitted to intensive care.

José RJ, Pfeffer PE, McDonald I, Shaw S, Padate B, McNamara C, Kibbler C, Agarwal B.

Br J Anaesth. 2012 Aug;109(2):291-2. doi: 10.1093/bja/aes242. No abstract available.

18.

Organ-specific management and supportive care in chronic graft-versus-host disease.

Dignan FL, Scarisbrick JJ, Cornish J, Clark A, Amrolia P, Jackson G, Mahendra P, Taylor PC, Shah P, Lightman S, Fortune F, Kibbler C, Andreyev J, Albanese A, Hadzic N, Potter MN, Shaw BE; Haemato-oncology Task Force of British Committee for Standards in Haematology; British Society for Blood and Marrow Transplantation.

Br J Haematol. 2012 Jul;158(1):62-78. doi: 10.1111/j.1365-2141.2012.09131.x. Epub 2012 Apr 26.

PMID:
22533889
19.

Developing best practice for fungal specimen submission--fungal audit of general practice.

Lasseter G, McNulty CA, Palmer M, Yoxall H, Kibbler C; Health Protection Agency GP Microbiology Laboratory Use Group.

Mycoses. 2012 Nov;55(6):476-82. doi: 10.1111/j.1439-0507.2012.02183.x. Epub 2012 Mar 26.

PMID:
22448663
20.

A practical critique of antifungal treatment guidelines for haemato-oncologists.

Agrawal S, Jones B, Barnes R, Kibbler C, Millen M, Ashcroft M, Jain S, Last A, Lewis D, Lewis T, Patel M, Pagliuca A.

Crit Rev Microbiol. 2012 Aug;38(3):203-16. doi: 10.3109/1040841X.2011.645521. Epub 2012 Feb 11. Review.

PMID:
22324737
21.

From the patient to the clinical mycology laboratory: how can we optimise microscopy and culture methods for mould identification?

Vyzantiadis TA, Johnson EM, Kibbler CC.

J Clin Pathol. 2012 Jun;65(6):475-83. doi: 10.1136/jclinpath-2011-200500. Epub 2012 Feb 3. Review.

PMID:
22308268
22.

Developing best practice for fungal specimen management: audit of UK microbiology laboratories.

Lasseter G, Palmer M, Morgan J, Watts J, Yoxall H, Kibbler C, McNulty C; HPA GP Microbiology Laboratory Use Group.

Br J Biomed Sci. 2011;68(4):197-202.

PMID:
22263434
23.

ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia.

Arendrup MC, Bille J, Dannaoui E, Ruhnke M, Heussel CP, Kibbler C.

Bone Marrow Transplant. 2012 Aug;47(8):1030-45. doi: 10.1038/bmt.2011.246. Epub 2012 Jan 9. Review.

PMID:
22231461
24.

Detection and identification of bacteria in clinical samples by 16S rRNA gene sequencing: comparison of two different approaches in clinical practice.

Jenkins C, Ling CL, Ciesielczuk HL, Lockwood J, Hopkins S, McHugh TD, Gillespie SH, Kibbler CC.

J Med Microbiol. 2012 Apr;61(Pt 4):483-8. doi: 10.1099/jmm.0.030387-0. Epub 2011 Dec 8.

PMID:
22160310
25.

European expert opinion on the management of invasive candidiasis in adults.

Kullberg BJ, Verweij PE, Akova M, Arendrup MC, Bille J, Calandra T, Cuenca-Estrella M, Herbrecht R, Jacobs F, Kalin M, Kibbler CC, Lortholary O, Martino P, Meis JF, Muñoz P, Odds FC, De Pauw BE, Rex JH, Roilides E, Rogers TR, Ruhnke M, Ullmann AJ, Uzun Ö, Vandewoude K, Vincent JL, Donnelly JP.

Clin Microbiol Infect. 2011 Sep;17 Suppl 5:1-12. doi: 10.1111/j.1469-0691.2011.03615.x.

26.

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation.

Marks DI, Pagliuca A, Kibbler CC, Glasmacher A, Heussel CP, Kantecki M, Miller PJ, Ribaud P, Schlamm HT, Solano C, Cook G; IMPROVIT Study Group.

Br J Haematol. 2011 Nov;155(3):318-27. doi: 10.1111/j.1365-2141.2011.08838.x. Epub 2011 Aug 22.

27.

Candida kefyr fungal enteritis following autologous BMT.

Direkze S, Mansour M, Rodriguez-Justo M, Kibbler C, Gant V, Peggs KS.

Bone Marrow Transplant. 2012 Mar;47(3):465-6. doi: 10.1038/bmt.2011.112. Epub 2011 May 30. No abstract available.

PMID:
21625228
28.

Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis.

Lanini S, Molloy AC, Fine PE, Prentice AG, Ippolito G, Kibbler CC.

BMC Med. 2011 Apr 12;9:36. doi: 10.1186/1741-7015-9-36. Review.

29.

Optimizing management of invasive mould diseases.

Agrawal S, Hope W, Sinkó J, Kibbler C.

J Antimicrob Chemother. 2011 Jan;66 Suppl 1:i45-53. doi: 10.1093/jac/dkq441. Review.

PMID:
21177403
30.

Melanin externalization in Candida albicans depends on cell wall chitin structures.

Walker CA, Gómez BL, Mora-Montes HM, Mackenzie KS, Munro CA, Brown AJ, Gow NA, Kibbler CC, Odds FC.

Eukaryot Cell. 2010 Sep;9(9):1329-42. doi: 10.1128/EC.00051-10. Epub 2010 Jun 11.

31.

Standards of care for patients with invasive fungal infections within the United Kingdom: a national audit.

Schelenz S, Barnes RA, Kibbler CC, Jones BL, Denning DW.

J Infect. 2009 Feb;58(2):145-53. doi: 10.1016/j.jinf.2008.12.006. Epub 2009 Jan 29.

PMID:
19185349
32.

Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here?

Balajee SA, Borman AM, Brandt ME, Cano J, Cuenca-Estrella M, Dannaoui E, Guarro J, Haase G, Kibbler CC, Meyer W, O'Donnell K, Petti CA, Rodriguez-Tudela JL, Sutton D, Velegraki A, Wickes BL.

J Clin Microbiol. 2009 Apr;47(4):877-84. doi: 10.1128/JCM.01685-08. Epub 2008 Dec 10. Review. No abstract available.

33.

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Clin Infect Dis. 2008 Jun 15;46(12):1813-21. doi: 10.1086/588660.

34.

Cutaneous infection with an Alternaria sp. in an immunocompetent host.

Williams C, Layton AM, Kerr K, Kibbler C, Barton RC.

Clin Exp Dermatol. 2008 Jul;33(4):440-2. doi: 10.1111/j.1365-2230.2007.02664.x. Epub 2008 Feb 28.

PMID:
18312460
35.

[Changes in invasive aspergillosis and candidiasis epidemiology].

Kibbler C.

Med Mal Infect. 2007;37 Suppl 2:2-4. Review. French.

PMID:
17933657
36.

Importance of the environment for patient acquisition of methicillin-resistant Staphylococcus aureus in the intensive care unit: a baseline study.

Wilson AP, Hayman S, Whitehouse T, Cepeda J, Kibbler C, Shaw S, Zelaya C, Cookson B, Singer M, Bellingan G.

Crit Care Med. 2007 Oct;35(10):2275-9.

PMID:
17944014
37.

Guidelines on the insertion and management of central venous access devices in adults.

Bishop L, Dougherty L, Bodenham A, Mansi J, Crowe P, Kibbler C, Shannon M, Treleaven J.

Int J Lab Hematol. 2007 Aug;29(4):261-78. Review.

PMID:
17617077
38.

Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series.

Fowler S, Webber A, Cooper BS, Phimister A, Price K, Carter Y, Kibbler CC, Simpson AJ, Stone SP.

J Antimicrob Chemother. 2007 May;59(5):990-5. Epub 2007 Mar 26.

PMID:
17387117
39.

The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection.

Stone SP, Cooper BS, Kibbler CC, Cookson BD, Roberts JA, Medley GF, Duckworth G, Lai R, Ebrahim S, Brown EM, Wiffen PJ, Davey PG.

J Antimicrob Chemother. 2007 May;59(5):833-40. Epub 2007 Mar 26. Review.

PMID:
17387116
40.

The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection.

Stone SP, Cooper BS, Kibbler CC, Cookson BD, Roberts JA, Medley GF, Duckworth G, Lai R, Ebrahim S, Brown EM, Wiffen PJ, Davey PG.

Lancet Infect Dis. 2007 Apr;7(4):282-8. Review.

PMID:
17376385
41.

Pathogen 'shift' in febrile neutropenia.

Kibbler CC, Prentice HG.

Curr Opin Infect Dis. 1999 Aug;12(4):351-4. No abstract available.

PMID:
17035798
42.

A reappraisal of current approaches to the management of fungal infections in neutropenic patients.

Kibbler CC, Prentice HG.

Curr Opin Infect Dis. 1998 Aug;11(4):397-400. No abstract available.

PMID:
17033401
43.

Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typing.

Odds FC, Davidson AD, Jacobsen MD, Tavanti A, Whyte JA, Kibbler CC, Ellis DH, Maiden MC, Shaw DJ, Gow NA.

J Clin Microbiol. 2006 Oct;44(10):3647-58.

44.

Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.

Pfaller MA, Diekema DJ, Colombo AL, Kibbler C, Ng KP, Gibbs DL, Newell VA.

J Clin Microbiol. 2006 Oct;44(10):3578-82.

45.
46.

A consensus on fungal polymerase chain reaction diagnosis?: a United Kingdom-Ireland evaluation of polymerase chain reaction methods for detection of systemic fungal infections.

White PL, Barton R, Guiver M, Linton CJ, Wilson S, Smith M, Gomez BL, Carr MJ, Kimmitt PT, Seaton S, Rajakumar K, Holyoake T, Kibbler CC, Johnson E, Hobson RP, Jones B, Barnes RA.

J Mol Diagn. 2006 Jul;8(3):376-84.

47.

Candidaemia in Europe: epidemiology and resistance.

Tortorano AM, Kibbler C, Peman J, Bernhardt H, Klingspor L, Grillot R.

Int J Antimicrob Agents. 2006 May;27(5):359-66. Epub 2006 Apr 27. Review.

PMID:
16647248
48.

Validation and clinical application of molecular methods for the identification of molds in tissue.

Paterson PJ, Seaton S, McHugh TD, McLaughlin J, Potter M, Prentice HG, Kibbler CC.

Clin Infect Dis. 2006 Jan 1;42(1):51-6. Epub 2005 Nov 29.

PMID:
16323091
49.

Defining invasive fungal infections in neutropenic or stem cell transplant patients.

Kibbler C.

J Antimicrob Chemother. 2005 Sep;56 Suppl 1:i12-i16. Review.

PMID:
16120629
50.

Molecular confirmation of invasive infection caused by Chaetomium globosum.

Paterson PJ, Seaton S, Yeghen T, McHugh TD, McLaughlin J, Hoffbrand AV, Kibbler CC.

J Clin Pathol. 2005 Mar;58(3):334. No abstract available.

Supplemental Content

Loading ...
Support Center